| Master Investor Magazine
|
AIM-listed beverages firm Fevertree Drinks (LON:FEVR) has seen its share price rise by 7.61% to 2,000p (as of 14:40 GMT) after it said trading had accelerated during the second half of the year ending 31st December. The company has also signed its first US bottling partner and production on the West Coast will begin in 2020.
CEO Tim Warrillow commented: “We continue to see growth across all four regions. Indeed, sales accelerated in our key growth markets of the US and Europe. Fever-Tree’s progress in the US is particularly encouraging and the signing of a US bottling partner is a further step in building our operations in this exciting market.
“Despite challenging comparators, our performance in the UK On-Trade underlines the strength of the brand and while the mixer category in the Off-Trade is moderating alongside the recent slowdown seen across the wider grocery channel, we continue to maintain our clear UK market leadership position“.